26.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen18.04.24 | Vollzeit | Planegg | Exact SciencesAppropriate. - Provide technical input and develop research plans, experimental outlines, and design. - Prepare and provide information and data for scientific abstracts, industry conferences, project meetings, or publication. - Present experimental results and defend scientific ideas and findings at group
Später ansehen27.03.24 | Vollzeit | Planegg | WipflerPLAN Planungsgesellschaft mbHDer Kläranlagenplanung oder der Siedlungswasserwirtschaft Softwarekenntnisse in AQUA DESIGNER oder Belebungs-Expert wünschenswert Sie bringen Organisationstalent mit, sind kommunikationsstark und treten souverän auf Unser Angebot Bei uns sind Sie flexibel Mit unserer Gleitzeitregelung können Sie Ihren Arbeitstag
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Planegg | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Designer in Planegg kostenlos abonnieren.